ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

NeuroImage: Clinical

Volumn 4, Issue , 2014, Pages 461-472

  Apostolova, Liana G ^a   Hwang, Kristy S ^a   Kohannim, Omid ^b   Avila, David ^a   Elashoff, David ^c   Jack Jr , Clifford R ^d   Shaw, Leslie ^e   Trojanowski, John Q ^e   Weiner, Michael W ^f,g   Thompson, Paul M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Abeta; ADNI; Alzheimer's disease; Diagnosis; Hippocampus atrophy; Tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; TAU PROTEIN; THREONINE; NERVE PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; SUPPORT VECTOR MACHINE; VERY ELDERLY; ALGORITHM; ATROPHY; CEREBROSPINAL FLUID; COGNITIVE DYSFUNCTION; COMPUTER ASSISTED DIAGNOSIS; MACHINE LEARNING; METABOLISM; ORGAN SIZE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ATROPHY; BIOMARKERS; COGNITIVE DYSFUNCTION; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIPPOCAMPUS; HUMANS; MACHINE LEARNING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGAN SIZE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84896512293     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2013.12.012     Document Type: Article

References (63)

1. N. Andreasen, L. Minthon, P. Davidsson, E. Vanmechelen, H. Vanderstichele, B. Winblad, and K. Blennow Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice Arch. Neurol. 58 2001 373 379
2. L.G. Apostolova, and P.M. Thompson Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment Neuropsychologia 46 2008 1597 1612
3. L.G. Apostolova, R.A. Dutton, I.D. Dinov, K.M. Hayashi, A.W. Toga, J.L. Cummings, and P.M. Thompson Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps Arch. Neurol. 63 2006 693 699
4. L.G. Apostolova, L. Mosconi, P.M. Thompson, A.E. Green, R. Mistur, W.H. Tsui, and M.J. de Leon Subregional hippocampal atrophy predicts future decline to Alzheimer's dementia in cognitively normal subjects Neurobiol. Aging 2014 10.1016/j.neurobiolaging.2008.08.008 (in press)
5. L.G. Apostolova, P.M. Thompson, A.E. Green, K.S. Hwang, C. Zoumalan, C.R. Jack Jr., D.J. Harvey, R.C. Petersen, L.J. Thal, P.S. Aisen, A.W. Toga, J.L. Cummings, and C.S. Decarli 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI Hum. Brain Mapp. 31 2010 786 797
6. L.G. Apostolova, K.S. Hwang, J.P. Andrawis, A.E. Green, S. Babakchanian, J.H. Morra, J.L. Cummings, A.W. Toga, J.Q. Trojanowski, L.M. Shaw, C.R. Jack Jr., R.C. Petersen, P.S. Aisen, W.J. Jagust, R.A. Koeppe, C.A. Mathis, M.W. Weiner, and P.M. Thompson 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects Neurobiol. Aging 31 2010 1284 1303
7. L.G. Apostolova, L. Mosconi, P.M. Thompson, A.E. Green, K.S. Hwang, A. Ramirez, R. Mistur, W.H. Tsui, and M.J. de Leon Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal Neurobiol. Aging 31 2010 1077 1088
8. L.G. Apostolova, J.H. Morra, A.E. Green, K.S. Hwang, C. Avedissian, E. Woo, J.L. Cummings, A.W. Toga, C.R. Jack, M.W. Weiner, and P.M. Thompson Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects Neuroimage 51 2010 488 499
9. K. Blennow, and H. Hampel CSF markers for incipient Alzheimer's disease Lancet Neurol. 2 2003 605 613
10. K. Blennow, A. Wallin, H. Agren, C. Spenger, J. Siegfried, and E. Vanmechelen Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26 1995 231 245
11. M. Bobinski, J. Wegiel, H.M. Wisniewski, M. Tarnawski, B. Reisberg, B. Mlodzik, M.J. de Leon, and D.C. Miller Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease Dementia 6 1995 205 210
12. M. Bobinski, J. Wegiel, M. Tarnawski, M. Bobinski, B. Reisberg, M.J. de Leon, D.C. Miller, and H.M. Wisniewski Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 414 420
13. M. Brys, E. Pirraglia, K. Rich, S. Rolstad, L. Mosconi, R. Switalski, L. Glodzik-Sobanska, S. De Santi, R. Zinkowski, P. Mehta, D. Pratico, L.A. Saint Louis, A. Wallin, K. Blennow, and M.J. de Leon Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment Neurobiol. Aging 30 2009 682 690
14. K. Buerger, S.J. Teipel, R. Zinkowski, K. Blennow, H. Arai, R. Engel, K. Hofmann-Kiefer, C. McCulloch, U. Ptok, R. Heun, N. Andreasen, J. DeBernardis, D. Kerkman, H. Moeller, P. Davies, and H. Hampel CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects Neurology 59 2002 627 629
15. K. Buerger, M. Ewers, N. Andreasen, R. Zinkowski, K. Ishiguro, E. Vanmechelen, S.J. Teipel, C. Graz, K. Blennow, and H. Hampel Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study Neurology 65 2005 1502 1503
16. C.M. Clark, S. Xie, J. Chittams, D. Ewbank, E. Peskind, D. Galasko, J.C. Morris, D.W. McKeel Jr., M. Farlow, S.L. Weitlauf, J. Quinn, J. Kaye, D. Knopman, H. Arai, R.S. Doody, C. DeCarli, S. Leight, V.M. Lee, and J.Q. Trojanowski Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60 2003 1696 1702
17. D.L. Collins, P. Neelin, T.M. Peters, and A.C. Evans Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space J. Comput. Assist. Tomogr. 18 1994 192 205
18. J.G. Csernansky, L. Wang, S. Joshi, J.P. Miller, M. Gado, D. Kido, D. McKeel, J.C. Morris, and M.I. Miller Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type Neurology 55 2000 1636 1643
19. Y. Cui, B. Liu, S. Luo, X. Zhen, M. Fan, T. Liu, W. Zhu, M. Park, T. Jiang, and J.S. Jin Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors PloS One 6 2011 e21896
20. C. Davatzikos, P. Bhatt, L.M. Shaw, K.N. Batmanghelich, and J.Q. Trojanowski Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Neurobiol. Aging 32 2011 e2319 e2327 (2322)
21. M.J. de Leon, S. DeSanti, R. Zinkowski, P.D. Mehta, D. Pratico, S. Segal, H. Rusinek, J. Li, W. Tsui, L.A. Saint Louis, C.M. Clark, C. Tarshish, Y. Li, L. Lair, E. Javier, K. Rich, P. Lesbre, L. Mosconi, B. Reisberg, M. Sadowski, J.F. DeBernadis, D.J. Kerkman, H. Hampel, L.O. Wahlund, and P. Davies Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment Neurobiol. Aging 27 2006 394 401
22. L. de Toledo-Morrell, B. Dickerson, M.P. Sullivan, C. Spanovic, R. Wilson, and D.A. Bennett Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease Hippocampus 10 2000 136 142
23. E. Dimitriadou, K. Hornik, F. Leisch, D. Meyer, and A. Weingessel e1071: Misc Functions of the Department of Statistics 2006 TU Wien e1071 (Available from http://cran.R-project.org)
24. M. Ewers, C. Walsh, J.Q. Trojanowski, L.M. Shaw, R.C. Petersen, C.R. Jack Jr., H.H. Feldman, A.L. Bokde, G.E. Alexander, P. Scheltens, B. Vellas, B. Dubois, M. Weiner, and H. Hampel Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance Neurobiol. Aging 33 2012 1203 1214
25. D.A. Fleischman, R.S. Wilson, J.D. Gabrieli, J.A. Schneider, J.L. Bienias, and D.A. Bennett Implicit memory and Alzheimer's disease neuropathology Brain 128 2005 2006 2015
26. Y. Freund, and R. Shapire A decision-theoretic generalization of online learning and an application to boosting J. Comp. Syst. Sci. 55 1997 119 139
27. G.B. Frisoni, A. Prestia, O. Zanetti, S. Galluzzi, M. Romano, M. Cotelli, M. Gennarelli, G. Binetti, L. Bocchio, B. Paghera, G. Amicucci, M. Bonetti, L. Benussi, R. Ghidoni, and C. Geroldi Markers of Alzheimer's disease in a population attending a memory clinic Alzheimers Dement. 5 2009 307 317
28. D. Galasko, L. Chang, R. Motter, C.M. Clark, J. Kaye, D. Knopman, R. Thomas, D. Kholodenko, D. Schenk, I. Lieberburg, B. Miller, R. Green, R. Basherad, L. Kertiles, M.A. Boss, and P. Seubert High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype Arch. Neurol. 55 1998 937 945
29. J. Gunter, M. Bernstein, B. Borowski, J. Felmlee, D. Blezek, and R. Mallozzi Validation testing of the MRI calibration phantom for the Alzheimer's Disease Neuroimaging Initiative Study ISMRM 14th Scientific Meeting and Exhibition 2006
30. I. Guyon, J. Waeston, S. Barnhill, and V. Vapnik Cancer classification using support vector machines Mach. Learn. 2002 389 422
31. H. Hampel, S.J. Teipel, T. Fuchsberger, N. Andreasen, J. Wiltfang, M. Otto, Y. Shen, R. Dodel, Y. Du, M. Farlow, H.J. Moller, K. Blennow, and K. Buerger Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment Mol. Psychiatry 9 2004 705 710
32. L.E. Hebert, L.A. Beckett, P.A. Scherr, and D.A. Evans Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050 Alzheimer Dis. Assoc. Disord. 15 2001 169 173
33. C.R. Jack Jr., R.C. Petersen, Y.C. Xu, S.C. Waring, P.C. O'Brien, E.G. Tangalos, G.E. Smith, R.J. Ivnik, and E. Kokmen Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease (see comment) Neurology 49 1997 786 794
34. C.R. Jack Jr., R.C. Petersen, Y. Xu, P.C. O'Brien, G.E. Smith, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease Neurology 51 1998 993 999
35. C.R. Jack Jr., R.C. Petersen, Y. Xu, P.C. O'Brien, G.E. Smith, R.J. Ivnik, B.F. Boeve, E.G. Tangalos, and E. Kokmen Rates of hippocampal atrophy correlate with change in clinical status in aging and AD Neurology 55 2000 484 489
36. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, D. Harvey, B. Borowski, P.J. Britson, C. Ward, A.M. Dale, J.P. Felmlee, J.L. Gunter, D.L. Hill, R. Killiany, N. Schuff, S. Fox-Bosetti, C. Lin, C. Studholme, C.S. DeCarli, G. Krueger, H.A. Ward, G.J. Metzger, K.T. Scott, R. Mallozzi, D. Blezek, J. Levy, J.P. Debbins, A.S. Fleisher, M. Albert, R. Green, G. Bartzokis, G. Glover, J. Mugler, and M.W. Weiner The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J. Magn. Reson. Imaging 27 2008 685 691
37. C.R. Jack Jr., H.J. Wiste, P. Vemuri, S.D. Weigand, M.L. Senjem, G. Zeng, M.A. Bernstein, J.L. Gunter, V.S. Pankratz, P.S. Aisen, M.W. Weiner, R.C. Petersen, L.M. Shaw, J.Q. Trojanowski, and D.S. Knopman Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease Brain 133 2010 3336 3348
38. C.R. Jack, H.J. Wiste, T.G. Lesnick, S.D. Weigand, D.S. Knopman, P. Vemuri, V.S. Pankratz, M.L. Senjem, J.L. Gunter, M.M. Mielke, V.J. Lowe, B.F. Boeve, and R.C. Petersen Brain beta-amyloid load approaches a plateau Neurology 80 2013 890 896
39. G.A. Jicha, J.E. Parisi, D.W. Dickson, K. Johnson, R. Cha, R.J. Ivnik, E.G. Tangalos, B.F. Boeve, D.S. Knopman, H. Braak, and R.C. Petersen Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia Arch. Neurol. 63 2006 674 681
40. J. Jovicich, S. Czanner, D. Greve, E. Haley, A. van der Kouwe, R. Gollub, D. Kennedy, F. Schmitt, G. Brown, J. Macfall, B. Fischl, and A. Dale Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data Neuroimage 30 2006 436 443
41. O. Kohannim, X. Hua, D.P. Hibar, S. Lee, Y.Y. Chou, A.W. Toga, C.R. Jack Jr., M.W. Weiner, and P.M. Thompson Boosting power for clinical trials using classifiers based on multiple biomarkers Neurobiol. Aging 31 2010 1429 1442
42. A.D. Leow, A.D. Klunder, C.R. Jack Jr., A.W. Toga, A.M. Dale, M.A. Bernstein, P.J. Britson, J.L. Gunter, C.P. Ward, J.L. Whitwell, B.J. Borowski, A.S. Fleisher, N.C. Fox, D. Harvey, J. Kornak, N. Schuff, C. Studholme, G.E. Alexander, M.W. Weiner, and P.M. Thompson Longitudinal stability of MRI for mapping brain change using tensor-based morphometry Neuroimage 31 2006 627 640
43. N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S.K. Herukka, W.M. van der Flier, M.A. Blankenstein, M. Ewers, K. Rich, E. Kaiser, M. Verbeek, M. Tsolaki, E. Mulugeta, E. Rosen, D. Aarsland, P.J. Visser, J. Schroder, J. Marcusson, M. de Leon, H. Hampel, P. Scheltens, T. Pirttila, A. Wallin, M.E. Jonhagen, L. Minthon, B. Winblad, and K. Blennow CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 2009 385 393
44. J. Mazziotta, A. Toga, A. Evans, P. Fox, J. Lancaster, K. Zilles, R. Woods, T. Paus, G. Simpson, B. Pike, C. Holmes, L. Collins, P. Thompson, D. MacDonald, M. Iacoboni, T. Schormann, K. Amunts, N. Palomero-Gallagher, S. Geyer, L. Parsons, K. Narr, N. Kabani, G. Le Goualher, D. Boomsma, T. Cannon, R. Kawashima, and B. Mazoyer A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM) Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 2001 1293 1322
45. J.H. Morra, Z. Tu, L.G. Apostolova, A.E. Green, C. Avedissian, S.K. Madsen, N. Parikshak, X. Hua, A.W. Toga, C.R. Jack Jr., M.W. Weiner, and P.M. Thompson Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls Neuroimage 43 2008 59 68
46. J.H. Morra, Z. Tu, L.G. Apostolova, A.E. Green, A.W. Toga, and P.M. Thompson Automatic subcortical segmentation using a contextual model Med. Image Comput. Comput. Assist. Interv. 11 2008 194 201
47. J.H. Morra, Z. Tu, L.G. Apostolova, A.E. Green, C. Avedissian, S.K. Madsen, N. Parikshak, A.W. Toga, C.R. Jack Jr., N. Schuff, M.W. Weiner, and P.M. Thompson Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls Neuroimage 45 2009 S3 15
48. J.H. Morra, Z. Tu, L.G. Apostolova, A. Green, A.W. Toga, and P.M. Thompson Comparison of adaboost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation IEEE Trans. Med. Imaging 29 2009 30 43
49. J.A. Mortimer, K.M. Gosche, K.P. Riley, W.R. Markesbery, and D.A. Snowdon Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study Neurology 62 2004 428 432
50. S.G. Mueller, and M.W. Weiner Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields Hippocampus 19 2009 558 564
51. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, D.J. Harvey, C.R. Jack Jr., W.J. Jagust, L.M. Shaw, A.W. Toga, J.Q. Trojanowski, and M.W. Weiner Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
52. M. Riemenschneider, N. Lautenschlager, S. Wagenpfeil, J. Diehl, A. Drzezga, and A. Kurz Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment Arch. Neurol. 59 2002 1729 1734
53. B. Schonheit, R. Zarski, and T.G. Ohm Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology Neurobiol. Aging 25 2004 697 711
54. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, R.C. Petersen, K. Blennow, H. Soares, A. Simon, P. Lewczuk, R. Dean, E. Siemers, W. Potter, V.M. Lee, and J.Q. Trojanowski Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann. Neurol. 65 2009 403 413
55. J.G. Sled, A.P. Zijdenbos, and A.C. Evans A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Trans. Med. Imaging 17 1998 87 97
56. V. Vapnik The Nature of Statistical Learning Theory 1995 Springer New York
57. P. Vemuri, H.J. Wiste, S.D. Weigand, L.M. Shaw, J.Q. Trojanowski, M.W. Weiner, D.S. Knopman, R.C. Petersen, and C.R. Jack Jr. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change Neurology 73 2009 294 301
58. P. Vemuri, H.J. Wiste, S.D. Weigand, L.M. Shaw, J.Q. Trojanowski, M.W. Weiner, D.S. Knopman, R.C. Petersen, and C.R. Jack Jr. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations Neurology 73 2009 287 293
59. S. Vos, I. van Rossum, L. Burns, D. Knol, P. Scheltens, H. Soininen, L.O. Wahlund, H. Hampel, M. Tsolaki, L. Minthon, R. Handels, G. L'Italien, W. van der Flier, P. Aalten, C. Teunissen, F. Barkhof, K. Blennow, R. Wolz, D. Rueckert, F. Verhey, and P.J. Visser Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI Neurobiol. Aging 33 2012 2272 2281
60. K.B. Walhovd, A.M. Fjell, J. Brewer, L.K. McEvoy, C. Fennema-Notestine, D.J. Hagler Jr., R.G. Jennings, D. Karow, and A.M. Dale Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease AJNR Am. J. Neuroradiol. 31 2010 347 354
61. A.K. Wallin, K. Blennow, N. Andreasen, and L. Minthon CSF biomarkers for Alzheimer's disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival Dement. Geriatr. Cogn. Disord. 21 2006 131 138
62. E. Westman, J.S. Muehlboeck, and A. Simmons Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion Neuroimage 62 2012 229 238
63. C. Zarow, H.V. Vinters, W.G. Ellis, M.W. Weiner, D. Mungas, L. White, and H.C. Chui Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia Ann. Neurol. 57 2005 896 903